Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Active support for stem cell research is key to alleviate incurable chronic diseases

Active support for stem cell research is key to alleviate incurable chronic diseases

Starving pancreatic cancer cells of cysteine may induce tumor ferroptosis

Starving pancreatic cancer cells of cysteine may induce tumor ferroptosis

New blood test detects more than 50 types of cancer, including at early, more treatable stages

New blood test detects more than 50 types of cancer, including at early, more treatable stages

New blood test accurately detects more than 50 types of cancer

New blood test accurately detects more than 50 types of cancer

Overview of prognostic and predictive factors in pancreatic cancer

Overview of prognostic and predictive factors in pancreatic cancer

A miRNA signature linked to local-regional failure and overall survival after pancreatic cancer resection

A miRNA signature linked to local-regional failure and overall survival after pancreatic cancer resection

MicroRNA dysregulation has critical impacts on development, inflammation and cancer development

MicroRNA dysregulation has critical impacts on development, inflammation and cancer development

Characterization of DNAm status of MMPs and TIMPs in atheromatous plaques

Characterization of DNAm status of MMPs and TIMPs in atheromatous plaques

Microbial DNA in the blood could help identify who has cancer

Microbial DNA in the blood could help identify who has cancer

Research introduces a new concept of resectability in pancreatic cancer

Research introduces a new concept of resectability in pancreatic cancer

Combination of anti-cancer nanodrugs with Intralipid enhances therapeutic efficacy

Combination of anti-cancer nanodrugs with Intralipid enhances therapeutic efficacy

The Pancreatic Cancer Collective awards additional funding of $16 million for new therapies

The Pancreatic Cancer Collective awards additional funding of $16 million for new therapies

New type of adoptive cell therapy could target prostate and pancreatic cancers in humans

New type of adoptive cell therapy could target prostate and pancreatic cancers in humans

Researchers establish a gene expression profile associated with cachexia in cancer patients

Researchers establish a gene expression profile associated with cachexia in cancer patients

Targeted therapy may increase overall survival in patients with pancreatic cancer

Targeted therapy may increase overall survival in patients with pancreatic cancer

Canada's cancer burden will increase in 2020 as population ages

Canada's cancer burden will increase in 2020 as population ages

Advances in surgical care for patients with pancreatic cancer

Advances in surgical care for patients with pancreatic cancer

Using newly discovered immune cell type to fight pancreatic cancer

Using newly discovered immune cell type to fight pancreatic cancer

Pancreatic cancer 'time machine' reveals tumor development and invasion

Pancreatic cancer 'time machine' reveals tumor development and invasion

NPF names Rush as National Center of Excellence for Pancreatic Cancer

NPF names Rush as National Center of Excellence for Pancreatic Cancer